BUSINESS

• Lonsurf Cuts Risk of Death by 31% in Metastatic Gastric Cancer
  June 26, 2018

• Meiji, Hiroshima Univ. Spinout Hook Up on Cell Therapies for Osteoarthritis
  June 26, 2018

• Xofluza Likely to Jolt Japan Flu Market This Winter
  June 25, 2018

• J-TEC Enters License Agreement on Low-Cost Manufacturing of CAR-T Cells with 2 Universities
  June 25, 2018

• Kowa Sues Towa for Damages Caused by Livalo Generics
  June 25, 2018

• Generic Specialist Ohara to Develop Novel Liver Cirrhosis Treatment Licensed from Japanese Startup
  June 25, 2018

• Maviret Sweeping Japan Hep C Market, 80% Share Snatched in Just 4 Months?
  June 22, 2018

• Nippon Zoki Applies for Approval of 3-Day Fentanyl Patch for Cancer Pain
  June 22, 2018

• AbbVie, Eisai Launch Pediatric Formulation of Humira
  June 22, 2018

• AstraZeneca Completes Transfer of Migraine Drug Zomig to Sawai
  June 21, 2018

• Remicade Biosimilar Gets New Dosage Nod for Psoriasis, Crohn’s Disease: Nichi-Iko/Ayumi
  June 21, 2018

• Desalex Most Promoted for GPs in April amid Pollen Season: Anterio
  June 20, 2018

• PII Data Suggest Acucela’s Emixustat Improves Macular Edema
  June 20, 2018

• Enbrel 25 mg Pen Now Available: Pfizer/Takeda
  June 19, 2018

• Quizartinib Cuts Risk of Death by 24% for AML: Daiichi Sankyo
  June 19, 2018

• Nichi-Iko to Roll Out Enbrel Biosimilar under License Deal with Lupin
  June 19, 2018

• Onychomycosis Treatment Efinaconazole Approved in Taiwan: Kaken, Mitsubishi Tanabe
  June 18, 2018

• CSL Behring Japan Chief Eyes Double-Digit Growth for Next Few Years
  June 18, 2018

• Shionogi Bags Some Asian Rights for Sage’s Depression Drug
  June 15, 2018

• Authorized Generics for Aimix, Cravit IV Bag Hit Shelves; Takepron Out in September
  June 15, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 381
• 382
• 383
• 384
• 385
• 386
• 387
• 388
• 389
• …
• Next ›
• 最終 »